Next Generation News and Research

RSS

Separating sperm and eggs from somatic cells preserves genetic building blocks

We have hundreds of types of cells in our bodies - everything from red blood cells to hair follicles to neurons. But why can't most of them create offspring for us?

23 May 2014

Commercial Cloud: Next-generation solution for life sciences companies

To an audience of more than 850 industry leaders at the Veeva Commercial Summit in Philadelphia, Veeva Systems unveiled Commercial Cloud - a next-generation solution to redefine how life sciences companies go to market.

22 May 2014

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company's second-generation EnligHTN™ renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. The results were presented during a hot line late-breaking clinical trial session at EuroPCR 2014.

22 May 2014

New online training module greatly improves medical student clinical skills

An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.

22 May 2014

AHC Enterprises, Duet Health announce launch of Visit Helper program

AHC Enterprises, a subsidiary of the Health Collaborative of Greater Columbus, and Duet Health announced today the launch of Visit Helper, now available at visithelper.com, iTunes, and Google Play.

21 May 2014

Researchers show how bacteria responsible for strep throat can be used to fight colon cancer

Researchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer. By engineering a streptococcal bacterial toxin to attach itself to tumour cells, they are forcing the immune system to recognize and attack the cancer.

21 May 2014

Veeva Commercial Cloud: Next-generation solution for life sciences companies

To an audience of more than 850 industry leaders at the Veeva Commercial Summit, Veeva Systems unveiled Commercial Cloud - a next-generation solution to redefine how life sciences companies go to market.

20 May 2014

New study provides evidence that bacteria in gut may be linked to children with autism

Children with autism spectrum disorders (ASD) have significantly different concentrations of certain bacterial-produced chemicals, called metabolites, in their feces compared to children without ASD.

20 May 2014

Optegra top tips for healthy eyes this hayfever season

This year's hayfever season is upon us: the temperatures and pollen count start to rise, noses are beginning to run and eyes are starting to itch.

20 May 2014

LifeBond to present LifeMesh self-fixating hernia mesh platform at MIXiii Biomed Conference

LifeBond Ltd., a leading developer of absorbable biosurgical products for tissue repair, announced today its new self-fixating hernia mesh platform, LifeMesh, which will be presented at the upcoming MIXiii Biomed Conference, to be held at the Israel Convention Center in Tel Aviv on May 20-22.

20 May 2014

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.

16 May 2014

UH pharmacy students earn awards for excellence in leadership, professional service and clinical skills from TSHP

University of Houston (UH) pharmacy students wrapped up the spring semester with a round of awards for excellence in leadership, professional service and clinical skills.

16 May 2014

Researchers test genomic sequencing for women with triple negative breast cancer

Indiana University cancer researchers are testing whether therapy incorporating advanced genomic technology will provide better outcomes than current treatments for those with an aggressive form of breast cancer.

15 May 2014

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Epilepsy is a group of neurological disorders often characterized by seizures and cognitive impairment due to electrical disturbances in the brain.

From Quest Diagnostics 14 May 2014

Novozymes Biopharma, ThioLogics to collaborate on drug-albumin conjugation platform

Novozymes Biopharma has entered a new collaboration with UK-based biotechnology company, ThioLogics. The collaboration brings together Novozymes' modified recombinant human albumin (rAlbumin) Veltis technology, with ThioLogics' site-specific next generation maleimide conjugation platform. This allows Novozymes to offer the pharma industry serum stable albumin drug conjugates with enhanced pharmacokinetic and/or targeting capabilities.

14 May 2014

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

North Shore Hematology Oncology Associates and Caris Life Sciences today announced a collaboration to establish a personalized cancer care program for patients in the greater Long Island area.

12 May 2014

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex Corporation today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™.

From Luminex 12 May 2014

Nursing student wins prestigious 2014 Patricia G. Archbold Predoctoral Scholar Award from NHCGNE

The National Hartford Centers of Gerontological Nursing Excellence (NHCGNE) has selected Darina Petrovsky for its prestigious 2014 Patricia G. Archbold Predoctoral Scholar Award.

9 May 2014

St. Jude Medical presents new data on quadripolar technology at Heart Rhythm 2014

St. Jude Medical, Inc., a global medical device company, is the leader in quadripolar technology with the only cardiac resynchronization therapy (CRT) system approved in the U.S. New data presented at Heart Rhythm 2014, the Heart Rhythm Society's Annual Scientific Sessions, demonstrates increased survival, improved clinical outcomes and better cost utilization with St. Jude Medical's quadripolar technology.

9 May 2014

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

Significant funding from NIBIB has enabled researchers to develop a unique technology to help physicians perform ultrasound-guided procedures involving needle placement such as needle biopsies, central line insertion, and local anesthesia.

8 May 2014

Next Generation News and Research

Separating sperm and eggs from somatic cells preserves genetic building blocks

Commercial Cloud: Next-generation solution for life sciences companies

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

New online training module greatly improves medical student clinical skills

AHC Enterprises, Duet Health announce launch of Visit Helper program

Researchers show how bacteria responsible for strep throat can be used to fight colon cancer

Veeva Commercial Cloud: Next-generation solution for life sciences companies

New study provides evidence that bacteria in gut may be linked to children with autism

Optegra top tips for healthy eyes this hayfever season

LifeBond to present LifeMesh self-fixating hernia mesh platform at MIXiii Biomed Conference

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

UH pharmacy students earn awards for excellence in leadership, professional service and clinical skills from TSHP

Researchers test genomic sequencing for women with triple negative breast cancer

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Novozymes Biopharma, ThioLogics to collaborate on drug-albumin conjugation platform

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Nursing student wins prestigious 2014 Patricia G. Archbold Predoctoral Scholar Award from NHCGNE

St. Jude Medical presents new data on quadripolar technology at Heart Rhythm 2014

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News